Literature DB >> 8864938

An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.

R P Hobson1, F M MacKenzie, I M Gould.   

Abstract

A predominantly hospital-based outbreak of multiply-resistant Klebsiella pneumoniae capsular type K2 (MRK) expressing expanded spectrum betalactamase (ESBL) activity and fully sensitive only to the carbapenems and amikacin is described. The organism was isolated from 283 patients between March 1992 and September 1995. The outbreak started in the intensive care unit (ICU) of a major acute hospital and spread through surgical wards, a medical ward, a geriatric unit in a separate hospital and various other local hospitals. Environmental screening revealed extensive ward contamination. The decline of the outbreak after the spring of 1995 coincided with the re-emphasis of standard infection control procedures and the launch of a works programme aimed at addressing underlying sites of environmental contamination. Of the 283 cases, 166 (59.0%) were detected through a specially instigated case finding programme. The MRK caused 11 cases of septicaemia, two postoperative intra-abdominal abscesses, one case of postoperative meningitis, 102 cases of urinary tract infection and 28 wound infections and was isolated from the respiratory tracts of five patients with ventilator associated pneumonia. The difficulty in controlling the outbreak is ascribed to heavy environmental contamination, frequent inter- and intra-hospital patient transfers and prolonged carriage of the outbreak strain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864938     DOI: 10.1016/s0195-6701(96)90011-0

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  17 in total

1.  SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.

Authors:  M Yuan; L M Hall; P H Savelkoul; C M Vandenbroucke-Grauls; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage rates in a laboratory model system.

Authors:  P Aranega-Bou; R P George; N Q Verlander; S Paton; A Bennett; G Moore
Journal:  J Hosp Infect       Date:  2018-12-18       Impact factor: 3.926

3.  Transferable resistance to cefotaxime, ceftazidime, and aztreonam and production of extended-spectrum beta-lactamase in a strain of Salmonella enteritidis.

Authors:  J Blahová; K Králiková; V Krcméry; K Kubonová
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

Review 4.  Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.

Authors:  Stephanie J Dancer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile Infection.

Authors:  Jacob E Simmering; Linnea A Polgreen; David R Campbell; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-15       Impact factor: 3.254

6.  Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit.

Authors:  J Royle; S Halasz; G Eagles; G Gilbert; D Dalton; P Jelfs; D Isaacs
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  Failure to control an outbreak of qnrA1-positive multidrug-resistant Enterobacter cloacae infection despite adequate implementation of recommended infection control measures.

Authors:  Armand Paauw; Jan Verhoef; Ad C Fluit; Hetty E M Blok; Titia E M Hopmans; Annet Troelstra; Maurine A Leverstein-van Hall
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

9.  Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.

Authors:  Rubens Clayton da Silva Dias; Armando Alves Borges-Neto; Giovanna Ianini D'Almeida Ferraiuoli; Márcia P de-Oliveira; Lee W Riley; Beatriz Meurer Moreira
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-27       Impact factor: 2.803

10.  Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit.

Authors:  Adebola O Ajao; J Kristie Johnson; Anthony D Harris; Min Zhan; Jessina C McGregor; Kerri A Thom; Jon P Furuno
Journal:  Infect Control Hosp Epidemiol       Date:  2013-05       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.